Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th:
H&E Equipment Services, Inc. (HEES - Free Report) : This integrated equipment services company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.8% over the last 60 days.
H&E Equipment Services, Inc. Price and Consensus
This Zacks Rank #1 (Buy) company has a dividend yield of 2.81%, compared with the industry average of 0.71%. Its five-year average dividend yield is 3.30%.
H&E Equipment Services, Inc. Dividend Yield (TTM)
BCB Bancorp, Inc. (BCBP - Free Report) : This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.8% over the last 60 days.
BCB Bancorp, Inc. (NJ) Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.84%, compared with the industry average of 1.43%. Its five-year average dividend yield is 4.56%.
BCB Bancorp, Inc. (NJ) Dividend Yield (TTM)
Escalade, Incorporated (ESCA - Free Report) : This sporting goods seller has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
Escalade, Incorporated Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.43%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.60%.
Escalade, Incorporated Dividend Yield (TTM)
Statoil ASA : This energy company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.
Statoil ASA Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.68%, compared with the industry average of 2.76%. Its five-year average dividend yield is 4.44%.
Statoil ASA Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th:
H&E Equipment Services, Inc. (HEES - Free Report) : This integrated equipment services company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.8% over the last 60 days.
H&E Equipment Services, Inc. Price and Consensus
This Zacks Rank #1 (Buy) company has a dividend yield of 2.81%, compared with the industry average of 0.71%. Its five-year average dividend yield is 3.30%.
H&E Equipment Services, Inc. Dividend Yield (TTM)
BCB Bancorp, Inc. (BCBP - Free Report) : This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.8% over the last 60 days.
BCB Bancorp, Inc. (NJ) Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.84%, compared with the industry average of 1.43%. Its five-year average dividend yield is 4.56%.
BCB Bancorp, Inc. (NJ) Dividend Yield (TTM)
Escalade, Incorporated (ESCA - Free Report) : This sporting goods seller has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
Escalade, Incorporated Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.43%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.60%.
Escalade, Incorporated Dividend Yield (TTM)
Statoil ASA : This energy company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.
Statoil ASA Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.68%, compared with the industry average of 2.76%. Its five-year average dividend yield is 4.44%.
Statoil ASA Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HEES - FREE
Get the latest research report on ESCA - FREE
Get the latest research report on BCBP - FREE